Gallus Biopharmaceuticals logo
VerifiedBiotechnology Research· Founded 2011

Gallus Biopharmaceuticals

September 30, 2014 - Gallus BioPharmaceuticals, LLC has been acquired by DPx Holdings B.V, privately owned by JLL Partners and Royal DSM and the parent company of Patheon. Patheon’s biologic drug substance business, a unit of DPx Holdings, now spans four global facilities in Europe, Australia and North America and includes more than 550 employees. Please visit the Patheon LinkedIn page to learn more about our expanded capabilities and to follow Patheon. Visit our website at

7-day free trial · no credit card

HeadquartersSt. Louis, United StatesEmployees62(201 to 500)Annual revenue$1B+Founded year2011Websitepatheon.comLinkedIn profileLinkedIn

Verified contacts

34

available on Kipplo

LinkedIn employees

62

201 to 500 range

Open roles

no listings

Distinct roles

33

indexed titles

Tech stack

0

tools in use

Monthly traffic

organic / mo

Sign up free to see all 34 verified contacts at Gallus Biopharmaceuticals

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

34 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Gallus Biopharmaceuticals

33 distinct titles indexed · top 10 shown.

  • 2production supervisor
  • 1administrative services supervisor
  • 1buyer
  • 1cell culture tech
  • 1cell culture technician
  • 1cmms coordinator
  • 1coordinator qs qad
  • 1entertainment specialist iv
  • 1lead mechanic
  • 1logistics coordinator
  • +23more titles

Sign up to unlock all 34 contacts at Gallus Biopharmaceuticals

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 34 verified contacts at Gallus Biopharmaceuticals

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Gallus Biopharmaceuticals | Kipplo Discover